| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $465K | — | — |
| Cost of Revenue | $387K | — | — |
| Gross Profit | $78K | — | — |
| R&D Expense | $2.1M | — | — |
| SG&A Expense | $4.3M | — | +845.3% |
| Operating Income | -$6.6M | — | -1374.9% |
| Pre-tax Income | -$133.1M | — | -154.4% |
| Income Tax | -$27.3M | — | -153.1% |
| Net Income | -$105.9M | — | -154.7% |
| EPS (Basic) | -$11.86 | — | -699.0% |
| EPS (Diluted) | -$11.86 | — | -699.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $159.7M | +2739.9% | — |
| Accounts Receivable | $370K | +4.3% | -74.3% |
| Current Assets | $551.2M | +5.2% | +13.9% |
| Total Assets | $551.2M | +5.2% | +13.9% |
| Current Liabilities | $3.0M | -22.6% | -3.1% |
| Total Liabilities | $40.4M | -41.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | — |
| Financing Cash Flow | $155.5M | — | — |
| -35.7% |
| Stockholders' Equity | $510.9M | +12.1% | +21.3% |